April 17, 2018 / 11:14 AM / 3 months ago

BRIEF-Anavex Life Sciences To Initiate Phase 2 Study Of Anavex®2-73 In Parkinson’S Disease Dementia

April 17 (Reuters) - Anavex Life Sciences Corp:

* ANAVEX LIFE SCIENCES TO INITIATE PHASE 2 STUDY OF ANAVEX®2-73 IN PARKINSON’S DISEASE DEMENTIA AND PROVIDES CLINICAL STUDY UPDATE FOR ANAVEX®2-73 IN RETT SYNDROME

* ANAVEX LIFE SCIENCES CORP - PLANS TO INITIATE PHASE 2 CLINICAL TRIAL OF ANAVEX 2-73 IN PARKINSON’S DISEASE DEMENTIA (PDD) IN H2 2018

* ANAVEX LIFE SCIENCES - ANTICIPATES POTENTIAL INITIATION OF ANAVEX 2-73 PHASE 2 STUDY IN RETT SYNDROME IN H2 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below